The AVYIA Journal
All Articles · Page 4
The latest ketamine research explained in plain language, real patient case studies, and practical guides for your mental health.
Archive
Page 4 of 7
Refining the Dose: Intravenous Ketamine as Adjunctive Therapy for Treatment-Resistant Depression
Ketamine at 0.5–1.0 mg/kg provides rapid relief in TRD patients, with higher efficacy than low doses, as shown in a placebo-controlled trial.
Restoring Hope: Repeated Ketamine Infusions Significantly Reduce Suicidal Ideation in Veterans with PTSD and MDD
Repeated ketamine infusions rapidly reduce suicidal thoughts in veterans with PTSD and depression, offering fast, sustained relief.
Reclaiming Calm: Ketamine’s Potential Role in Treating Resistant PTSD
Ketamine may offer rapid, short-term relief for treatment-resistant PTSD by restoring emotional balance and reducing traumatic symptoms.
Rewiring the Reward Circuit: How Ketamine Enhances Emotional Processing in Depression
Ketamine restores emotional responsiveness in depression by enhancing brain reward circuits and reducing negative emotional bias.
Rewriting the Future: Ketamine’s Promise for Treatment-Resistant Mood Disorders
Ketamine offers rapid relief for depression and bipolar disorder, reshaping psychiatric care for treatment-resistant cases.
Breaking Through in India: Ketamine Therapy Demonstrates Sustained Relief in Severe Depression
An Indian trial shows ketamine’s rapid and lasting antidepressant effects in drug-free patients with severe depression.
Stopping the Spiral: Ketamine Offers Emergency Relief for Acute Suicidal Ideation
A single IV ketamine dose rapidly reduced suicidal ideation in ER patients—88% in remission within 90 minutes, study finds.
A Promising Pattern: Meta-Analysis Reveals Strong, Sustained Antidepressant Effects of Ketamine in Treatment-Resistant Depression
A meta-analysis confirms ketamine’s fast and sustained antidepressant effects in treatment-resistant depression.
Resetting the Circuitry: Prolonged Ketamine Infusions Show Sustained Benefits for Treatment-Resistant Depression
A 96-hour ketamine infusion may offer long-term relief for treatment-resistant depression and modulate key brain circuits.
Breaking the Cycle: Repeated Ketamine Infusions Show Promise for Chronic PTSD
Repeated ketamine infusions reduce chronic PTSD symptoms fast, offering relief for those unresponsive to standard treatment.
Rewiring Hope: Ketamine and the Rise of Rapid-Acting Antidepressants
Ketamine offers fast relief for depression, reshaping psychiatric care. Explore how it inspires a new era of rapid-acting antidepressants.
Mapping Recovery: Neuroimaging Markers Predicting Ketamine Response in PTSD
fMRI reveals amygdala-vmPFC connectivity as a predictor of ketamine treatment success in patients with PTSD, enabling personalized care.
OnlineTalk to ProviderCall us